EUVIMEDEUVIMED entdecken
Crossref

New-onset diabetes after kidney transplantation: Assessing urinary Wilm's tumor-1 protein to predict renal allograft dysfunction

César Endrigo Silva de Andrade, Karla Simone Costa de Souza, Ony Araújo Galdino, Mabelle Alves Ferreira de Lima, Paulo José de Medeiros, Marcela Abbott Galvão Ururahy, Maurício Galvão Pereira, José Bruno de Almeida, Adriana Augusto de Rezende

Advances in Medical Sciences · 2024

DOI: 10.1016/j.advms.2024.03.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Medical Sciences, 2024. Verfasst von César Endrigo Silva de Andrade und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Integrated Medicine, Federal University of Rio Grande do Norte, Natal, RN, Brazil. Hauptthemen laut MEDLINE: Kidney Transplantation, Glomerular Filtration Rate, WT1 Proteins, Diabetes Mellitus. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Coordination of Higher Education Personnel Improvement, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: New-onset diabetes after transplantation (NODAT) is a frequent metabolic complication associated with podocyte damage and renal allograft dysfunction. Thus, Wilm's tumor-1 (WT-1) protein, as a podocyte marker, holds promise as an option to evaluate renal allograft dysfunction in NODAT. Therefore, the study aimed to investigate urinary WT-1 levels in NODAT patients during the first year after kidney transplantation (KTx). MATERIALS AND METHODS: KTx patients were categorized into non-NODAT and NODAT groups. Fasting blood glucose, glycated hemoglobin (HbA1c), urinary albumin/creatinine ratio (ACR), serum creatinine, estimated glomerular filtration rate (eGFR), and urinary WT-1 were measured at 3, 6, 9, and 12-months post-KTx. RESULTS: The NODAT group manifested elevated levels of blood glucose and HbA1c during the first year post-KTx. Also, exhibited elevations in ACR and serum creatinine levels at 6, 9, and 12-months post-KTx when compared to non-NODAT group. Conversely, eGFR values in the NODAT group demonstrated significant declines at 3, 6, and 9-months post-KTx relative to non-NODAT. Furthermore, NODAT group exhibited a median annual eGFR of 47 ​mL/min/1.73 ​m2. Urinary WT-1 levels at 3, 6, 9, and 12-months post-KTx were significantly higher in the NODAT group compared to non-NODAT. Additionally, noteworthy positive correlations were identified between urinary WT-1 and HbA1c levels, along with significant negative correlations between urinary WT-1 and eGFR at the 3, 6, 9, and 12-months post-KTx. CONCLUSION: The increased urinary WT-1 levels from 3-months post-KTx in NODAT patients may indicate the first sign of podocyte injury, predicting a renal allograft dysfunction in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationGlomerular Filtration RateWT1 ProteinsDiabetes MellitusHumansMaleFemaleMiddle AgedAdultBiomarkersAllograftsPrognosisFollow-Up StudiesGlycated Hemoglobin

Stichwörter der Autor:innen

Kidney transplantationNew-onset diabetes after transplantationRenal allograft dysfunctionUrineWilm's tumor-1

Substanzen

WT1 ProteinsBiomarkersWT1 protein, humanGlycated Hemoglobin

Autor:innen und Institutionen

  • Division of Nephrology, Department of Integrated Medicine, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
  • Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
  • Department of Nutrition, Federal University of Rio Grande do Norte, Natal, RN, Brazil.
  • Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal, RN, Brazil. Electronic address: adriana.rezende@ufrn.br.

Förderung

  • Coordination of Higher Education Personnel Improvement
  • National Council for Scientific and Technological Development

Zitieren

APA

de Andrade, C. E. S., Souza, K. S. C., Galdino, O. A., de Lima, M. A. F., de Medeiros, P. J., Abbott Galvão Ururahy, M., Pereira, M. G., de Almeida, J. B., & de Rezende, A. A. (2024). New-onset diabetes after kidney transplantation: Assessing urinary Wilm's tumor-1 protein to predict renal allograft dysfunction. Advances in Medical Sciences. https://doi.org/10.1016/j.advms.2024.03.002

Vancouver

de Andrade CES, Souza KSC, Galdino OA, de Lima MAF, de Medeiros PJ, Abbott Galvão Ururahy M, et al. New-onset diabetes after kidney transplantation: Assessing urinary Wilm's tumor-1 protein to predict renal allograft dysfunction. Advances in Medical Sciences. 2024. doi:10.1016/j.advms.2024.03.002

BibTeX
@article{deAndrade2024,
  author = {de Andrade, César Endrigo Silva and Souza, Karla Simone Costa de and Galdino, Ony Araújo and de Lima, Mabelle Alves Ferreira and de Medeiros, Paulo José and Abbott Galvão Ururahy, Marcela and Pereira, Maurício Galvão and de Almeida, José Bruno and de Rezende, Adriana Augusto},
  title = {New-onset diabetes after kidney transplantation: Assessing urinary Wilm's tumor-1 protein to predict renal allograft dysfunction},
  journal = {Advances in Medical Sciences},
  year = {2024},
  doi = {10.1016/j.advms.2024.03.002}
}
Kostenlos starten →